title: Soluble leptin receptor and insulin resistance as determinant of sleep apnea.
abstract: OBJECTIVE
  To investigate the possible associations between sleep apnea syndrome, hyperinsulinemia/insulin resistance and hyperleptinemia in subjects with different degrees of body mass index.
  
  
  METHODS
  To test for the presence or absence of sleep apnea syndrome in association with hyperinsulinemia/insulin resistance and hyperleptinemia.
  
  
  METHODS
  Twenty subjects with different body mass index (mean BMI 30.9+/-4.2).
  
  
  METHODS
  Insulin action and plasma soluble leptin receptor were measured by euglycemic hyperinsulinemic glucose clamp and by ELISA method, respectively. Occurrence of sleep apnea syndrome was assessed by clinical and nocturnal monitoring using a validated sleep apnea recorder.
  
  
  RESULTS
  The apnea/hypopnea index (AHI) was positively correlated with plasma soluble leptin receptor (0.76; P<0.001) and negatively with the degree of insulin-mediated glucose uptake (r=-0.73; P<0.001). In a multivariate analysis AHI was associated with plasma soluble leptin receptor and insulin mediated glucose uptake independently of age, gender, BMI, plasma leptin levels and PaCO(2).
  
  
  CONCLUSIONS
  Sleep apnea syndrome is associated with plasma soluble leptin receptor and insulin resistance independently of BMI.
authors.affiliation: Dipartimento di Gerontologia, Geriatria e Malattie del Metabolismo-II University of Naples, Naples, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Manzella
authors.forename: M
authors.initials: M
authors.lastname: Parillo
authors.forename: T
authors.initials: T
authors.lastname: Razzino
authors.forename: P
authors.initials: P
authors.lastname: Gnasso
authors.forename: S
authors.initials: S
authors.lastname: Buonanno
authors.forename: A
authors.initials: A
authors.lastname: Gargiulo
authors.forename: M
authors.initials: M
authors.lastname: Caputi
authors.forename: G
authors.initials: G
authors.lastname: Paolisso
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002245:Carbon Dioxide / Q000032:analysis; D002352:Carrier Proteins / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015309:Glucose Clamp Technique; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood; D008297:Male; D008875:Middle Aged; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D012891:Sleep Apnea Syndromes / Q000209:etiology*; D012995:Solubility; D014280:Triglycerides / Q000097:blood
chemical_list: D002352:Carrier Proteins; D007328:Insulin; C515448:LEPR protein, human; D020738:Leptin; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D014280:Triglycerides; D002245:Carbon Dioxide